Suppr超能文献

[复方激素避孕——哪种避孕药适合哪位患者?]

[Combined Hormonal Contraception - Which Pill for Which Patient?].

作者信息

Quaas Philipp

机构信息

Frauenklinik, Universitätsspital Basel, Universität Basel, Basel, Schweiz.

出版信息

Praxis (Bern 1994). 2023;112(4):205-210. doi: 10.1024/1661-8157/a003993.

Abstract

Combined Hormonal Contraception - Which Pill for Which Patient? Combined hormonal contraceptives (CHC) are a valuable and highly effective option in contraceptive counseling. Methods and preparations available in Switzerland are combined oral contraceptives (COC), vaginal rings and transdermal patches. All preparations contain an estrogen and a progestin component. The estrogen component mainly consists of the synthetically produced ethinylestradiol (EE), although newer COC may contain natural estrogens such as estradiol (E2) and estetrol (E4). For the progestin component, a variety of luteal body hormones are available, which enable the health care professional to prescribe a "tailored" product for the patient due to their different partial effects. The individual thromboembolism (TE) risk should always be considered and taken into account when prescribing CHC.

摘要

复方激素避孕——为哪位患者选择哪种避孕药?复方激素避孕药(CHC)是避孕咨询中一种有价值且高效的选择。瑞士可用的方法和制剂有复方口服避孕药(COC)、阴道环和透皮贴剂。所有制剂都含有雌激素和孕激素成分。雌激素成分主要由合成的炔雌醇(EE)组成,不过新型COC可能含有天然雌激素,如雌二醇(E2)和雌三醇(E4)。对于孕激素成分,有多种黄体激素可供选择,由于它们不同的部分作用,医疗保健专业人员能够为患者开出“量身定制”的产品。在开具CHC处方时,应始终考虑并顾及个体血栓栓塞(TE)风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验